Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson's disease

被引：0
|
作者：
Fischer, D.
Auinger, P.
Goudreau, J.
Cole-Strauss, A.
Kieburtz, K.
Elm, J.
Hacker, M.
Charles, P.
Lipton, J.
Pickut, B.
Sortwell, C.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
91
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease
    Fischer, D. Luke
    Auinger, Peggy
    Goudreau, John L.
    Cole-Strauss, Allyson
    Kieburtz, Karl
    Elm, Jordan J.
    Hacker, Mallory L.
    Charles, P. David
    Lipton, Jack W.
    Pickut, Barbara A.
    Sortwell, Caryl E.
    [J]. NEUROTHERAPEUTICS, 2020, 17 (04) : 1785 - 1795
  • [2] BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease
    D. Luke Fischer
    Peggy Auinger
    John L. Goudreau
    Allyson Cole-Strauss
    Karl Kieburtz
    Jordan J. Elm
    Mallory L. Hacker
    P. David Charles
    Jack W. Lipton
    Barbara A. Pickut
    Caryl E. Sortwell
    [J]. Neurotherapeutics, 2020, 17 : 1785 - 1795
  • [3] Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? No
    Friedman, Andrzej
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (02) : S10 - S13
  • [4] Bdnf rs6265 and Other Variants Predict the Efficacy of Levodopa Monotherapy in Early-Stage Parkinson's Disease
    Sortwell, C.
    Auinger, P.
    Goudreau, J.
    Pickut, B.
    Hacker, M.
    Charles, P.
    Lipton, J.
    Cole-Strauss, A.
    Elm, J.
    Fischer, D.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S195 - S195
  • [5] Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes
    Szczudlik, Andrzej
    Rudzinska, Monika
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2007, 41 (02) : S6 - S9
  • [6] Tolcapone and the prevention of depression in patients with early-stage Parkinson's disease initiating levodopa
    Lew, M. F.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S657 - S657
  • [7] Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease
    Manza, Peter
    Schwartz, Guy
    Masson, Mala
    Kann, Sarah
    Volkow, Nora D.
    Li, Chiang-shan R.
    Leung, Hoi-Chung
    [J]. NEUROBIOLOGY OF AGING, 2018, 66 : 12 - 22
  • [8] Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy
    Miah, I. P.
    Dubbelink, K. T. Olde
    Stoffers, D.
    Deijen, J. B.
    Berendse, H. W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) : 510 - 516
  • [9] The early treatment of Parkinson's disease: levodopa, dopamine agonists or both
    Stern, MB
    [J]. PARKINSONISM & RELATED DISORDERS, 2000, 7 (01) : 27 - 33
  • [10] Serum somatostatin in early-stage Parkinson's disease
    Shiraishi, M.
    Kobayashi, T.
    Watanabe, H.
    Kamo, T.
    Hasegawa, Y.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (04): : 225 - 229
12345